Description
Semaglutide reduces blood glucose in a glucose dependent manner by simulating insulin secretion and lowering glucagon secretion when blood glucose is high. The mechanism of blood glucose lowering also involves a minor delay in gastric emptying. During hypoglycemia, Semaglutide diminishes insulin secretion and does not impair glucagon secretion. Semaglutide reduces body weight and body fat mass by an overall reduced appetite.
In general, more weight loss and better blood glucose control are seen with higher Ozempic doses. During a 40-week study, people receiving the 1 mg Ozempic dose lost an average of 13 lbs.
Reviews
There are no reviews yet.